Skip to main content

Table 1 Population characteristics

From: Free breathing three-dimensional cardiac quantitative susceptibility mapping for differential cardiac chamber blood oxygenation – initial validation in patients with cardiovascular disease inclusive of direct comparison to invasive catheterization

Age 63 ± 10yo
Gender (% male) 31% (12)
Known CAD 56% (22)
Pulmonary Hypertension 51% (20)
Atherosclerosis Risk Factors
Tobacco Use (prior or current) 46% (18)
Hypertension 67% (26)
Hyperlipidemia 54% (21)
Diabetes mellitus 18% (7)
Medication Regimen
ACE Inhibitors or ARB 51% (20)
Beta-Blockers 72% (28)
Aspirin 74% (29)
Statin 69% (27)
Diuretic 46% (18)
Cardiac Structure/Function
LVEF (%) 49 ± 14%
LV Dysfunction (EF < 50%) 49% (19)
LV End-Diastolic Volume 186 ± 57 ml
LV End-Systolic Volume 106 ± 56 ml
RV EF (%) 51 ± 11%
RV Dysfunction (EF < 50%) 31% (12)
RV End-Diastolic Volume 169 ± 62 ml
RV End-Systolic Volume 96 ± 52 ml
  1. Data reported as % (n) for categorical variables, mean standard deviation for continuous variables
  2. ACE angiotensin converting enzyme, ARB angiotensin receptor blocker, CAD coronary artery disease, EF ejection fraction, LV left ventricle, RV right ventricular